# SmartPill Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/smartpill

- Industry: Medical Devices & Equipment
- Headquarters: Buffalo, US
- Website: www.smartpillcorp.com
- Total disclosed funding: $20M
- Latest round: Series B (Jul 22, 2008)
- Investors on record: 3

## About

SmartPill Corporation operates in the healthcare sector, specializing in domain name sales targeted at businesses seeking to enhance their digital presence in pharmaceuticals and wellness industries.SmartPill Corporation is focused on providing a domain name for sale, catering to businesses aiming to establish themselves online in the healthcare space. In October 2010, Given Imaging acquired SmartPill Corporation for USD 6 mn. The company is headquartered in Buffalo, US.SmartPill Corporation offers a domain name, specifically aimed at businesses or individuals looking to create an online presence related to healthcare and pharmaceuticals. The core offering is the domain name that can support various applications, including e-commerce, informational platforms, and medication management. The target customers include startups and established firms in the health tech sector, with the domain's market being global, allowing for broad accessibility across different regions.SmartPill Corporation's revenue model is centered on the sale or leasing of its domain name, which is priced at USD 1,495 or an installment plan of USD 62.29 per month over 24 months. Revenue is generated from direct transactions with customers, with options for upfront payments or payment plans, catering to both startups and established businesses in the healthcare and pharmaceutical industries.Following the acquisition by Given Imaging in October 2010, SmartPill Corporation plans to enhance its product offerings by expanding the range of ancillary services related to the domain, such as privacy protection features. The company is targeting further growth by exploring additional markets in Europe and Asia by 2025, leveraging its existing customer base. The recent funding from the acquisition will be utilized to support these initiatives.

## Funding rounds

- Series B, Jul 22, 2008, $20M — Oxford Bioscience Partners, Psilos Group, Primary Venture Partners

## Investors

- Oxford Bioscience Partners (https://capitalatlas.ai/funds/oxford-bioscience-partners) — Series B
- Psilos Group (https://capitalatlas.ai/funds/psilos-group) — Series B
- Primary Venture Partners (https://capitalatlas.ai/funds/primary-venture-partners) — Series B